Business · 17/02/2005Updated: 10/17/2026 · 1 min read
FDA Announces Joint Meeting of Dermatologic and Ophthalmic Drugs Advisory Committee and Nonprescription Drugs Advisory Committee
Summary
The FDA has scheduled a joint meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee to discuss various topics related to dermatologic and ophthalmic drugs, as well as nonprescription drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →